Study examined safety of polatuzumab vedotin in first line treatment of DLBCL.
Home / Resource Library / Safety profiles in elderly patients with DLBCL on first-line Pola-R-CHP: a claims database study in Japan
Study examined safety of polatuzumab vedotin in first line treatment of DLBCL.